Carregant...

Treatment of respiratory syncytial virus infection with recombinant interferon alfa-2a.

A prospective randomised, double blind, controlled trial was conducted in 52 infants to determine whether recombinant interferon alfa-2a (INF-alpha-2a) would reduce the morbidity of acute bronchiolitis and the respiratory syncytial virus shedding time. All infants had a positive direct antigen immun...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Sung, R Y, Yin, J, Oppenheimer, S J, Tam, J S, Lau, J
Format: Artigo
Idioma:Inglês
Publicat: 1993
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC1029552/
https://ncbi.nlm.nih.gov/pubmed/8259875
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!